Dasatinib
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Dasatinib (ncit:C38713)
RxNorm: dasatinib (rxcui:475342, omop:1358436)
SNOMED: Dasatinib (sctid:423658008, omop:4307995)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (3) | BCR::ABL1 | Chronic Myelogenous Leukemia | Dasatinib | |
| FDA (3) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Dasatinib | |
| FDA (2) | BCR::ABL1 | Acute Lymphoid Leukemia | Dasatinib | |
| EMA (3) | BCR::ABL1 | Chronic Myelogenous Leukemia | Dasatinib | |
| EMA (2) | BCR::ABL1 | Acute Lymphoid Leukemia | Dasatinib |